Literature DB >> 16125294

Cognitive discernible factors between schizophrenia and schizoaffective disorder.

Emmanuel Stip1, Amir Ali Sepehry, Antoinette Prouteau, Catherine Briand, Luc Nicole, Pierre Lalonde, Alain Lesage.   

Abstract

BACKGROUND: Schizophrenia (SZ) and schizoaffective disorders (SA) are associated with cognitive deficits. Generally, a schizoaffective diagnosis is associated with better prognosis on the level of social integration. It is also well established that cognition is an important factor for good social outcome in schizophrenia. We hypothesized that, although patients suffering from SA share symptoms with SZ, they can be differentiated on the basis of neurocognitive function and that SA perform better in several domains.
METHOD: Performances of two groups SA (N = 13) and SZ (N = 44) were compared on several visual-motor tasks using CANTAB [Motor Screening (MOT), Reaction Time (RTI), Paired Associates Learning Task (PAL), and Stockings of Cambridge items (SOC)]. The two groups were matched for symptom severity. ANOVA with repeated measures was employed to determine whether any difference in cognitive scores during a 2-year period was significantly related to the diagnostic status.
RESULTS: A significant and durable difference was observed between SZ and SA on motor screening and explicit memory tests where SA performed better.
CONCLUSION: Neurocognitive tests may be relevant for distinguishing schizoaffective from schizophrenia, chiefly via tests tapping into visuo-spatial and visuo-motor coordination abilities (e.g., paired associated learning and motor screening).

Entities:  

Mesh:

Year:  2005        PMID: 16125294     DOI: 10.1016/j.bandc.2005.07.003

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  17 in total

1.  Deficient maturation of aspects of attention and executive functions in early onset schizophrenia.

Authors:  Jens Richardt M Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Anne Marie R Christensen; Merete Nordentoft; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-08-01       Impact factor: 4.785

Review 2.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 3.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

4.  Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.

Authors:  Kathryn E Lewandowski; Bruce M Cohen; Matcheri S Keshavan; Dost Ongür
Journal:  Schizophr Res       Date:  2011-10-12       Impact factor: 4.939

Review 5.  New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.

Authors:  T J Bussey; A Holmes; L Lyon; A C Mar; K A L McAllister; J Nithianantharajah; C A Oomen; L M Saksida
Journal:  Neuropharmacology       Date:  2011-04-21       Impact factor: 5.250

Review 6.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

7.  Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different.

Authors:  A Owoso; C S Carter; J M Gold; A W MacDonald; J D Ragland; S M Silverstein; M E Strauss; D M Barch
Journal:  Psychol Med       Date:  2013-03-25       Impact factor: 7.723

8.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

9.  Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Authors:  S Kristian Hill; James L Reilly; Richard S E Keefe; James M Gold; Jeffrey R Bishop; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

Review 10.  [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].

Authors:  B Voss; R Thienel; S Leucht; T Kircher
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.